Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10598805rdf:typepubmed:Citationlld:pubmed
pubmed-article:10598805lifeskim:mentionsumls-concept:C1273518lld:lifeskim
pubmed-article:10598805lifeskim:mentionsumls-concept:C0035304lld:lifeskim
pubmed-article:10598805lifeskim:mentionsumls-concept:C0007758lld:lifeskim
pubmed-article:10598805lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:10598805lifeskim:mentionsumls-concept:C0017428lld:lifeskim
pubmed-article:10598805lifeskim:mentionsumls-concept:C0752125lld:lifeskim
pubmed-article:10598805lifeskim:mentionsumls-concept:C0443147lld:lifeskim
pubmed-article:10598805lifeskim:mentionsumls-concept:C0029237lld:lifeskim
pubmed-article:10598805pubmed:issue5lld:pubmed
pubmed-article:10598805pubmed:dateCreated2000-1-6lld:pubmed
pubmed-article:10598805pubmed:abstractTextAutosomal dominant cerebellar ataxia with retinal degeneration (ADCA type II) is a progressive neurodegenerative disorder caused by a CAG expansion in the spinocerebellar ataxia 7 (SCA7) gene. Here, we describe the genomic organisation of the human SCA7 gene. The exon-intron boundaries were identified by sequencing plasmid subclones of a P1 artificial chromosome (PAC) clone containing the entire SCA7 gene. We found 13 exons, ranging in size from 69 to 979 bp, with all exon-intron boundaries following the GT-AG rule. The ATG initiation codon at position 554 of the cDNA occurs in exon 3 at position 12 and the coding region extends to the first five codons of exon 13, with the CAG repeat being located in exon 3 starting at codon 30. The intron sizes were determined by long-distance polymerase chain reaction with primers from neighbouring exons and by restriction mapping of the SCA7 PAC clone. The introns varied in size from 233 bp to about 40 kb, resulting in an overall size estimate for the SCA7 gene of 140 kb. Sequence analysis of intron 7 (491 bp) revealed a polymorphic GT/AC repeat, a useful intragenic marker for SCA7 in segregation studies.lld:pubmed
pubmed-article:10598805pubmed:languageenglld:pubmed
pubmed-article:10598805pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10598805pubmed:citationSubsetIMlld:pubmed
pubmed-article:10598805pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10598805pubmed:statusMEDLINElld:pubmed
pubmed-article:10598805pubmed:monthNovlld:pubmed
pubmed-article:10598805pubmed:issn0340-6717lld:pubmed
pubmed-article:10598805pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:10598805pubmed:authorpubmed-author:MaugerCClld:pubmed
pubmed-article:10598805pubmed:authorpubmed-author:LöfgrenAAlld:pubmed
pubmed-article:10598805pubmed:authorpubmed-author:Del-FaveroJJlld:pubmed
pubmed-article:10598805pubmed:authorpubmed-author:MichalíkAAlld:pubmed
pubmed-article:10598805pubmed:issnTypePrintlld:pubmed
pubmed-article:10598805pubmed:volume105lld:pubmed
pubmed-article:10598805pubmed:ownerNLMlld:pubmed
pubmed-article:10598805pubmed:authorsCompleteYlld:pubmed
pubmed-article:10598805pubmed:pagination410-7lld:pubmed
pubmed-article:10598805pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:meshHeadingpubmed-meshheading:10598805...lld:pubmed
pubmed-article:10598805pubmed:year1999lld:pubmed
pubmed-article:10598805pubmed:articleTitleGenomic organisation of the spinocerebellar ataxia type 7 (SCA7) gene responsible for autosomal dominant cerebellar ataxia with retinal degeneration.lld:pubmed
pubmed-article:10598805pubmed:affiliationDepartment of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Antwerp, Belgium.lld:pubmed
pubmed-article:10598805pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10598805pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://bio2rdf.org/pubmed:1...skos:relatedMatchpubmed-article:10598805lld:mappings
entrez-gene:6314entrezgene:pubmedpubmed-article:10598805lld:entrezgene